Business ❯ Biotechnology

Drug Development

Clinical Research Artificial Intelligence Clinical Trials Regulatory Affairs Autoimmune Diseases Lifespan Extension Contract Research Organizations Regulatory Approval Funding Regulatory Compliance Computational Models Leadership Collaborations Therapies Neuro-immunology Antibody Discovery Therapeutics Pharmaceuticals Patent Expiration Pharmaceutical Industry Axovant Sciences Cancer Therapies FDA Approvals Animal Health

Chai Discovery Raises $130 Million Series B at $1.3 Billion Valuation

The AI biotech says the new capital will accelerate a computer‑aided design platform for molecules.

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

PsiThera Raises $47.5 Million and Appoints Eric Shaff as CEO to Push Oral TNF Small-Molecule Drugs

Biogen, Dayra Launch $50 Million Pact to Develop Oral Macrocyclic Peptides for Immunology

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing

NRG Therapeutics Raises £50M to Advance Mitochondrial Neurodegeneration Drug Into the Clinic

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market